133 related articles for article (PubMed ID: 2896307)
1. Successful symptomatic treatment of malignant carcinoid syndrome with the somatostatin analogue SMS 201-995.
van Houten AA; Nortier JW; Vendrik CP
Neth J Med; 1988 Apr; 32(3-4):194-8. PubMed ID: 2896307
[No Abstract] [Full Text] [Related]
2. Treatment of the malignant carcinoid syndrome. Evaluation of a long-acting somatostatin analogue.
Kvols LK; Moertel CG; O'Connell MJ; Schutt AJ; Rubin J; Hahn RG
N Engl J Med; 1986 Sep; 315(11):663-6. PubMed ID: 2427948
[TBL] [Abstract][Full Text] [Related]
3. The carcinoid syndrome.
Oates JA
N Engl J Med; 1986 Sep; 315(11):702-4. PubMed ID: 2875390
[No Abstract] [Full Text] [Related]
4. Tumor regression of an ileal carcinoid under the treatment with the somatostatin analogue SMS 201-995.
Wiedenmann B; Räth U; Rädsch R; Becker F; Kommerell B
Klin Wochenschr; 1988 Jan; 66(2):75-7. PubMed ID: 2894481
[TBL] [Abstract][Full Text] [Related]
5. [Carcinoid syndrome with a course of more than 10 years].
Baur X; Bortsch A; Autenrieth G; Jacob K; Neudert J; Schneider B; Werdan K
Internist (Berl); 1988 May; 29(5):347-50. PubMed ID: 2900222
[No Abstract] [Full Text] [Related]
6. Rapid reversal of carcinoid crisis with a somatostatin analogue.
Kvols LK; Martin JK; Marsh HM; Moertel CG
N Engl J Med; 1985 Nov; 313(19):1229-30. PubMed ID: 2865675
[No Abstract] [Full Text] [Related]
7. Use of a somatostatin analogue in association with surgery and hepatic arterial embolisation in the treatment of the carcinoid syndrome.
Ahlman H; Ahlund L; Dahlström A; Nilsson O; Skolnik G; Tisell LE; Tylén U
Br J Cancer; 1987 Dec; 56(6):840-2. PubMed ID: 2893640
[No Abstract] [Full Text] [Related]
8. [A favorable response to the somatostatin analog SMS 201-995 in a patient with the carcinoid syndrome].
Del Val A; Ponce J; Talens A; Martí-Bonmati L; Garrigues V; Berenguer J
Rev Esp Enferm Dig; 1991 Mar; 79(3):215-7. PubMed ID: 2043408
[TBL] [Abstract][Full Text] [Related]
9. [Usefulness of the somatostatin analog SMS 201-995 in the treatment of gastrinoma].
Gilsanz Peral A; Costa Talens P; Gómez Balaguer M
Med Clin (Barc); 1987 Jun; 89(3):131-2. PubMed ID: 2887718
[No Abstract] [Full Text] [Related]
10. An update of lanreotide acetate for treatment of adults with carcinoid syndrome.
Guadalupe E; Deshpande HA; Stein SM
Drugs Today (Barc); 2018 Aug; 54(8):457-465. PubMed ID: 30209440
[TBL] [Abstract][Full Text] [Related]
11. Somatostatin, anaesthesia, and the carcinoid syndrome. Peri-operative administration of a somatostatin analogue to suppress carcinoid tumour activity.
Roy RC; Carter RF; Wright PD
Anaesthesia; 1987 Jun; 42(6):627-32. PubMed ID: 2887127
[TBL] [Abstract][Full Text] [Related]
12. [Symptomatic treatment of the malignant carcinoid syndrome with octreotide].
Alberts AS; Falkson G
S Afr Med J; 1989 Jan; 75(1):30-1. PubMed ID: 2911781
[TBL] [Abstract][Full Text] [Related]
13. Long-term results of treatment of malignant carcinoid syndrome with prolonged release Lanreotide (Somatuline Autogel).
Khan MS; El-Khouly F; Davies P; Toumpanakis C; Caplin ME
Aliment Pharmacol Ther; 2011 Jul; 34(2):235-42. PubMed ID: 21585408
[TBL] [Abstract][Full Text] [Related]
14. Treatment of malignant carcinoid syndrome with a long-acting somatostatin analogue.
Altman AR; Tschen JA; Rice L
Arch Dermatol; 1989 Mar; 125(3):394-6. PubMed ID: 2923448
[TBL] [Abstract][Full Text] [Related]
15. [A prolonged-action somatostatin analog and carcinoid syndrome].
Chayvialle JA
Bull Acad Natl Med; 1989 May; 173(5):643-50; discussion 650-1. PubMed ID: 2478266
[TBL] [Abstract][Full Text] [Related]
16. Somatostatin analogue phase I trials in neuroendocrine neoplasms.
Anthony L; Johnson D; Hande K; Shaff M; Winn S; Krozely M; Oates J
Acta Oncol; 1993; 32(2):217-23. PubMed ID: 7686764
[TBL] [Abstract][Full Text] [Related]
17. Somatostatin analogue (SMS 201-995) in the management of gastroenteropancreatic tumors and diarrhea syndromes.
Vinik AI; Tsai ST; Moattari AR; Cheung P; Eckhauser FE; Cho K
Am J Med; 1986 Dec; 81(6B):23-40. PubMed ID: 2879447
[TBL] [Abstract][Full Text] [Related]
18. Gastrointestinal endocrine tumors: diagnosis and management. Role of somatostatin analogue SMS 201-995. July 4-6, 1986, Vancouver, British Columbia. Proceedings.
Am J Med; 1987 May; 82(5B):1-99. PubMed ID: 2884875
[No Abstract] [Full Text] [Related]
19. Metastatic carcinoid tumors and the carcinoid syndrome. A selective review of chemotherapy and hormonal therapy.
Kvols LK
Am J Med; 1986 Dec; 81(6B):49-55. PubMed ID: 2432781
[TBL] [Abstract][Full Text] [Related]
20. Neuroendocrine disorders of the gastroenteropancreatic system. Clinical applications of the somatostatin analogue SMS 201-995. April 2-4, 1986, San Diego, California.
Am J Med; 1986 Dec; 81(6B):1-101. PubMed ID: 2879445
[No Abstract] [Full Text] [Related]
[Next] [New Search]
